Molecular Biology Enzymes, Reagents And Kits Market Size, Share & Trends Analysis Report By Product (Kits, Reagents), By Application, By End-use, By Region- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

According to Nova one advisor, the global Molecular Biology Enzymes, Reagents And Kits market size is evaluated at USD 19.58 billion in 2022 and is expected to hit around USD 44.97 billion by 2030, growing at a CAGR of 9.98% from 2022 to 2030. 

Key Takeaways:

  • By product, the kits and reagents held the largest share in 2021. The launch of new kits and reagents in response to the pandemic is one of the key reasons fueling the growth. Moreover, the repeated use of molecular biology kits and reagents in laboratory setups contributes to the growth
  • By application, sequencing accounted for the largest share in 2021 due to the introduction of single-cell sequencing and the leading presence of NGS. Use of NGS for analysis of genomics, tumor diagnostics, and biomarker discovery fuels the segment growth
  • By end-use, the pharma and biotech segment held the largest share in 2021. The presence of drug development pipelines, clinical trials, and continuous R&D activities require huge usage of molecular biology enzymes, kits, and reagents, thus leading to the segment growth
  • North America held the largest revenue share in 2021. This is attributed to the presence of numerous key pharmaceutical and biotechnology companies in the U.S. Furthermore, the prevalence of diseases in this region and increased use of molecular diagnostics contribute to revenue generation

The consistently developing technologies in the field of molecular biology have resulted in a significant impact on the life science research that is being directed for the betterment of health and medical conditions. These research activities involving advanced molecular biology technologies are driving the usage of consumables, thus paving the path for designing innovative methods with a wide range of applications. The adoption rate of molecular biology enzymes, reagents, and kits is also increasing due to the growing use of bioinformatics and computational tools for genome analysis and drug discoveries.

The growth of the market globally can be attributed to continuous advancement in technologies in the molecular biology field, the prevalence of infectious and chronic diseases, increased usage of sequencing technologies and growing omics-based research activities.

The COVID-19 pandemic exponentially increased the demand for molecular biology enzymes, reagents, and kits, and the continuous rise in cases worldwide kept the demand on the higher side. Many market players, healthcare organizations, and academic and research institutes were actively engaged in the development of vaccines and they increased the research for repurposing the existing therapeutics for the treatment of COVID-19 infection. This continuous R&D activity is expected to boost the demand for these products in the coming years. Moreover, in an effort to detect the SARS-CoV-2 virus faster, many new products were launched by the key market players, such as RNA extraction kits. For example, in June 2020, Omega Bio-tek, Inc. announced the launch of its “Mag-Bind Viral RNA Xpress Kit” for RNA isolation in a reliable and rapid manner from the nasopharyngeal swab of patient samples.

Continuous funding and investments in the field of synthetic biology and multi-omics are expanding the field of biotechnology. As per a press release in March 2022, The Bristol Centre for Engineering Biology, BrisEngBio, is an institute that supports research and discovery in synthetic biology. It is a UKRI-funded research center that has published over 325 research papers, collaborated with 8 biotech companies, and received an additional USD 117.90 million for research. This rapidly advancing field of synthetic biology and multi-omics will result in more extensive adoption of molecular biology, enzymes, kits, and reagent products, which serve as educational tools. And this adoption rate further enhances the development of innovative methods such as drug discovery, diagnostics development, and gene therapies manufacturing, hence driving the market significantly.

The key market players are expanding their global presence through never-ceasing product launches and sustained technological developments. Acquisitions, partnerships, collaborations, and manufacturing expansions are also some of the business strategies taken up by the key players to drive revenue generation in the market. For example, in January 2022, Illumina, Inc. announced a partnership with SomaLogic to develop a product by integrating Illumina’s NGS technology with SomaScan Proteomics Assay. This partnership bolsters the rapidly growing high-throughput segment of the proteomics market.

Report Scope of the Molecular Biology Enzymes, Reagents And Kits Market

Report Coverage

Details

Market Size

USD 44.97 Billion by 2030

Growth Rate

CAGR of 9.98% from 2022 to 2030

Largest Market

North America

Fastest Growing Market

Asia Pacific

Base Year

2021

Forecast Period

2022 to 2030

Segments Covered

Product, application, end-use and Region,

Companies Mentioned

Thermo Fisher Scientific, Inc.; QIAGEN; Illumina, Inc.; F. Hoffmann-La Roche Ltd.; Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; New England Biolabs; Merck KGaA; Promega Corporation; Takara Bio, Inc.; LGC Limited

Product Insights

Kits and reagents held the largest share of over 65.10% in 2021. This can be attributed to the vast availability of these products in the market space, novel developments, and continuous product launches from key players, which was further fueled by the rising number of SARS-CoV-2 variants. For instance, PerkinElmer announced the launch of NEXTFLEX Variant-Seq SARS-CoV-2 Kit v2 in December 2021 for disease surveillance and enhancement of sequencing throughput and reliability for variant identification. The company further launched this kit, which is compatible with the Illumina platform, which further increases its utilization rate.

With the continuous growth of cloning technology as a routine laboratory practice along with increasing scope in molecular biology, enzymes are anticipated to witness the fastest growth in the forecast period. This has allowed the manufacturers and suppliers to provide multiple enzymes for nucleic acid manipulation. The presence of different sources of enzymes such as ligases, polymerases, nucleases, methylases, phosphatases, and topoisomerases for cloning applications has resulted in the advancement of cloning techniques. Moreover, efforts are taken by companies for developing novel and advanced enzymes. For example, in November 2021, Novozymes and Novo Nordisk collaborated to develop specialty enzymes for applications in biopharmaceutical production processes and are expected to launch new products within the next few years. Hence, all this will influence the lucrative growth of enzymes in the market.

Application Insights

Other applications dominated the market and held a revenue share of over 35.19% in 2021. The sequencing segment held the second-largest share in 2021 and is estimated to observe a significant growth rate of 10.88% from 2022 to 2030. This growth can be attributed to the increasing implementation of sequencing-based medical treatments and the application of sequencing in oncology. The use of NGS for analysis of genomics, tumor diagnostics, and biomarker discovery fuels the segment growth and drives the use of molecular biology consumables under this segment. Major companies are undertaking different business strategies to drive the segment. For instance, in January 2022, Pacific Biosciences collaborated with Berry Genomics for extending the use of its long-read sequencing technology to the clinical market in China. Such initiatives are anticipated to drive the segment in the near future.

The PCR segment is expected to grow at a steady growth rate in the coming years. An exponential increase in COVID-19 cases resulted in the increased production of real-time-PCR (RT-PCR) based detection kits as PCR tests became the golden standard for the detection of COVID-19. The accuracy and reliable results of genetic material detection increased its adoption across the globe. In addition, the advent of new technologies including ddPCR (droplet digital PCR) offers enhanced detection platforms. These advances and increasing applications of PCR are anticipated to continue driving revenue in this segment.

End-use Insights

The pharma and biotech segment held the largest share of over 35.18% in 2021. This is owing to a wide acceptance of molecular biology products such as PCR, sequencing, genotyping, and DNA/RNA extraction enzymes that make the workflow easier. The ease and efficiency of these products during the research for drug candidates, personalized medicine, or diagnostics of the pharma and biotech companies boost advancements of offerings and consequently increase their sales. Such huge implementation of molecular technologies by companies during R&D stages and clinical trials will drive the market in the forthcoming years.

The academic and research segment held a prominent share in 2021. The surge in demand for new diagnostics tools and treatment options for COVID-19 infection surged the demand for kits and reagents in research centers. Furthermore, the wide application of PCR and NGS fuels the progress in various research projects directed toward the development of health such as cancer, pathogenesis, and mutation. Government funding schemes towards these institutes are also contributing to the growth of the market due to the increased adoption of molecular biology consumables. For instance, in April 2021, the NIH awarded a grant worth USD 10.8 million to the University of Arkansas for the establishment of the Arkansas Integrative Metabolic Research Center, which would function as a Center of Biomedical Research Excellence.

Regional Insights

North America held the largest share of over 45.19% in 2021. The commonality of cancer within the population and the prevalence of chronic diseases across different age groups are increasing the research activities for prevention and treatment solutions. This consequently drives the demand for molecular products. The presence of well-established players, renowned research institutes, aggregated government, and private funding, developed healthcare settings, and ease of adoption of new technologies are considered to be the major factors fueling revenue generation in this region.

Asia Pacific is expected to register a productive growth rate in the forecast period. The poor healthcare services, high population, high demand for targeted therapies, and rapid economic growth have created lucrative growth opportunities for molecular biology manufacturers. Additionally, the increased spending power in these nations has encouraged western companies to launch new products and gain market share in these regions, consequently driving revenue in the market.

Some of the prominent players in the Molecular Biology Enzymes, Reagents And Kits Market include:

  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • QIAGEN
  • Promega Corporation
  • New England Biolabs
  • Merck KGaA
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Takara Bio, Inc.
  • LGC Limited

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Molecular Biology Enzymes, Reagents And Kits market

  • Product
    • Kits & Reagents
    • Enzymes
  • Application
    • Cloning
    • Sequencing
    • PCR
    • Epigenetics
    • Restriction Digestion
    • Other Applications
  • End-use
    • Pharma & Biotech
    • Academic & Research
    • Hospital & Diagnostics
    • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Molecular Biology Enzymes, Reagents And Kits industry analysis from 2022 to 2030 to identify the prevailing Molecular Biology Enzymes, Reagents And Kits industry opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the global Molecular Biology Enzymes, Reagents And Kits industry segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global Molecular Biology Enzymes, Reagents And Kits industry trends, key players, market segments, application areas, and market growth strategies.

Report Detail

  • Report Code:7563
  • No. of Pages:150+
  • Format:PDF/PPT/Excel

Proceed To Buy

USD 3500
USD 7000